Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 22 - Consensus views arising from the 55th Study Group: Cancer and Reproductive Health

  • from SECTION 8 - Consensus Views
  • Edited by Sean Kehoe, Eric Jauniaux, Pierre Martin-Hirsch, Philip Savage
  • Book:
    Cancer and Reproductive Health
    Published online:
    05 October 2014
    Print publication:
    01 November 2008, pp 281-284

  • Summary

    This chapter presents the consensus views arising from the 55th study group of cancer and reproductive health. A national cancer and pregnancy database should be developed to include data regarding the outcome of all cases of multiple pregnancies where there is a hydatidiform mole and a normal fetus. Further research into the pharmacokinetics of chemotherapeutic agents during pregnancy and lactation, and the effects on placenta, fetus and infant, is required. Guidelines should be developed for the use of frozen sections in pregnancy or otherwise. National standards of care and pathways should be produced to address the unique needs of cancer patients with regard to rapid access to fertility care. All cancer multidisciplinary teams should consider the possible consequences of cancer treatment for fertility and reproductive health. All molar pregnancies should be registered with the one of the three UK National Trophoblast Centres for follow-up.